Terms: = Liver cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Prognosis
17 results:
1. Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.
He J; Li W; Zhou J; Sun H; Zhou C; Liu Y; Quan T; Fan W; Pan Z; Lin J; Peng J
Eur J Radiol; 2023 Aug; 165():110950. PubMed ID: 37437437
[TBL] [Abstract] [Full Text] [Related]
2. The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal liver Metastases.
Shimura Y; Komatsu S; Nagatani Y; Funakoshi Y; Sofue K; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Yanagimoto H; Toyama H; Minami H; Fukumoto T
Ann Surg Oncol; 2023 Oct; 30(11):6603-6610. PubMed ID: 37386304
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of quantitative volumetric analysis and linear measurement for predicting the survival of Barcelona Clinic liver cancer 0- and A stage hepatocellular carcinoma after radiofrequency ablation.
Yang S; Zhang Z; Su T; Chen Q; Wang H; Jin L
Diagn Interv Radiol; 2023 May; 29(3):450-459. PubMed ID: 37154818
[TBL] [Abstract] [Full Text] [Related]
4. Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin-bilirubin grade.
Ko CC; Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
Int J Clin Oncol; 2022 Apr; 27(4):739-748. PubMed ID: 35119581
[TBL] [Abstract] [Full Text] [Related]
5.
van 't Erve I; Wesdorp NJ; Medina JE; Ferreira L; Leal A; Huiskens J; Bolhuis K; van Waesberghe JTM; Swijnenburg RJ; van den Broek D; Velculescu VE; Kazemier G; Punt CJA; Meijer GA; Fijneman RJA
JCO Precis Oncol; 2021; 5():. PubMed ID: 34820593
[TBL] [Abstract] [Full Text] [Related]
6. The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
Jiang T; Zhang XS; Pan F; Lyu SC; Wang J; Huang MX; He Q; Lang R
Medicine (Baltimore); 2021 Jul; 100(26):e26487. PubMed ID: 34190174
[TBL] [Abstract] [Full Text] [Related]
7. Viral integration drives multifocal HCC during the occult HBV infection.
Chen XP; Long X; Jia WL; Wu HJ; Zhao J; Liang HF; Laurence A; Zhu J; Dong D; Chen Y; Lin L; Xia YD; Li WY; Li GB; Zhao ZK; Wu K; Hou Y; Yu JJ; Xiao W; Wang GP; Zhu PC; Chen W; Bai MZ; Jian YX; Kristiansen K; Chen Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):261. PubMed ID: 31200735
[TBL] [Abstract] [Full Text] [Related]
8. A Novel Score Predicts HBV-Related Hepatocellular Carcinoma Recurrence After Hepatectomy: a Retrospective Multicenter Study.
Qin W; Wang L; Hu B; Leng S; Tian H; Luo H; Yao J; Chen X; Wu C; Chen G; Yang Y
J Gastrointest Surg; 2019 May; 23(5):922-932. PubMed ID: 30446938
[TBL] [Abstract] [Full Text] [Related]
9. A Fair Chance for Everyone: Total Tumor Volume as a Selection Tool in liver Transplantation for Hepatocellular Carcinoma.
Pinto-Marques H; Silva S; Sobral M; Perdigoto R; Martins A; Barroso E
Dig Surg; 2018; 35(6):539-548. PubMed ID: 29346782
[TBL] [Abstract] [Full Text] [Related]
10. Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma.
Li MX; Zhao H; Bi XY; Li ZY; Huang Z; Han Y; Zhou JG; Zhao JJ; Zhang YF; Wei WQ; Zhao DB; Cai JQ
Tumour Biol; 2016 Jul; 37(7):9301-10. PubMed ID: 26779628
[TBL] [Abstract] [Full Text] [Related]
11. [Squamous cell carcinoma (SCC)--nature and usage in patients with cervical carcinoma].
Bocheva Y; Bochev P; Chaushev B; Ivanov S
Akush Ginekol (Sofiia); 2015; 54(2):29-34. PubMed ID: 25909138
[TBL] [Abstract] [Full Text] [Related]
12. Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria.
Lee YH; Hsia CY; Hsu CY; Huang YH; Lin HC; Huo TI
World J Surg; 2013 Jun; 37(6):1348-55. PubMed ID: 23467925
[TBL] [Abstract] [Full Text] [Related]
13. Identification of the genes chemosensitizing hepatocellular carcinoma cells to interferon-α/5-fluorouracil and their clinical significance.
Sakabe T; Tsuchiya H; Kanki K; Azumi J; Gonda K; Mizuta Y; Yamada D; Wada H; Shomori K; Nagano H; Shiota G
PLoS One; 2013; 8(2):e56197. PubMed ID: 23457527
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection.
Ochiai T; Ikoma H; Okamoto K; Kokuba Y; Sonoyama T; Otsuji E
World J Surg; 2012 Jan; 36(1):136-43. PubMed ID: 22051887
[TBL] [Abstract] [Full Text] [Related]
15. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
Hsu CY; Huang YH; Chiou YY; Su CW; Lin HC; Lee RC; Chiang JH; Huo TI; Lee FY; Lee SD
Liver Transpl; 2011 May; 17(5):556-66. PubMed ID: 21506244
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy.
Huo TI; Hsu CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Chiang JH; Lee PC; Lee SD
BMC Gastroenterol; 2010 Dec; 10():146. PubMed ID: 21194431
[TBL] [Abstract] [Full Text] [Related]
17. Poor association of TT virus viremia with hepatocellular carcinoma.
Yoshida H; Kato N; Shiratori Y; Lan KH; Ono-Nita SK; Feng Z; Shiina S; Omata M
Liver; 2000 Jun; 20(3):247-52. PubMed ID: 10902976
[TBL] [Abstract] [Full Text] [Related]
